{"title":"特殊妇科和产科群体的COVID-19疫苗接种","authors":"María Antonia Buenaventura Rubio","doi":"10.19230/JONNPR.4187","DOIUrl":null,"url":null,"abstract":"espanolLa pandemia por COVID-19 y las serias repercusiones que esta teniendo han hecho que se agilice el desarrollo de un arma terapeutica fundamental para comenzar a erradicarla: las vacunas. Son un instrumento fundamental de prevencion primaria que se administrara inicialmente a los grupos mas vulnerables o con alto riesgo de exposicion, ampliando el abanico de administracion a otro tipo de poblacion en fases posteriores. Puede surgir controversia a la hora de vacunar a grupos ginecologicos especificos, como son las gestantes, mujeres lactantes o pacientes con cancer ginecologico. El proposito de este articulo es analizar la informacion disponible con respecto a la vacunacion en estos grupos. EnglishThe COVID-19 pandemic and its serious repercussions are accelerating the development of a fundamental therapeutic strategy to begin eradicating this illness: vaccines. They are a fundamental instrument of primary prevention that will be administer initially to vulnerable groups or those with high risk of exposure, expanding in later phases the administration to another populations. There can be controversy in vaccinating some specific gynecological groups, like pregnant women, lactating women or patients with gynecological cancer. The purpose of this article is to analyze the information available regarding vaccination in these concrete groups.","PeriodicalId":265734,"journal":{"name":"Jounal of Negative and No Positive Results","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Vacunación de COVID-19 en grupos ginecológicos y obstétricos especiales\",\"authors\":\"María Antonia Buenaventura Rubio\",\"doi\":\"10.19230/JONNPR.4187\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"espanolLa pandemia por COVID-19 y las serias repercusiones que esta teniendo han hecho que se agilice el desarrollo de un arma terapeutica fundamental para comenzar a erradicarla: las vacunas. Son un instrumento fundamental de prevencion primaria que se administrara inicialmente a los grupos mas vulnerables o con alto riesgo de exposicion, ampliando el abanico de administracion a otro tipo de poblacion en fases posteriores. Puede surgir controversia a la hora de vacunar a grupos ginecologicos especificos, como son las gestantes, mujeres lactantes o pacientes con cancer ginecologico. El proposito de este articulo es analizar la informacion disponible con respecto a la vacunacion en estos grupos. EnglishThe COVID-19 pandemic and its serious repercussions are accelerating the development of a fundamental therapeutic strategy to begin eradicating this illness: vaccines. They are a fundamental instrument of primary prevention that will be administer initially to vulnerable groups or those with high risk of exposure, expanding in later phases the administration to another populations. There can be controversy in vaccinating some specific gynecological groups, like pregnant women, lactating women or patients with gynecological cancer. The purpose of this article is to analyze the information available regarding vaccination in these concrete groups.\",\"PeriodicalId\":265734,\"journal\":{\"name\":\"Jounal of Negative and No Positive Results\",\"volume\":\"6 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jounal of Negative and No Positive Results\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.19230/JONNPR.4187\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jounal of Negative and No Positive Results","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19230/JONNPR.4187","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Vacunación de COVID-19 en grupos ginecológicos y obstétricos especiales
espanolLa pandemia por COVID-19 y las serias repercusiones que esta teniendo han hecho que se agilice el desarrollo de un arma terapeutica fundamental para comenzar a erradicarla: las vacunas. Son un instrumento fundamental de prevencion primaria que se administrara inicialmente a los grupos mas vulnerables o con alto riesgo de exposicion, ampliando el abanico de administracion a otro tipo de poblacion en fases posteriores. Puede surgir controversia a la hora de vacunar a grupos ginecologicos especificos, como son las gestantes, mujeres lactantes o pacientes con cancer ginecologico. El proposito de este articulo es analizar la informacion disponible con respecto a la vacunacion en estos grupos. EnglishThe COVID-19 pandemic and its serious repercussions are accelerating the development of a fundamental therapeutic strategy to begin eradicating this illness: vaccines. They are a fundamental instrument of primary prevention that will be administer initially to vulnerable groups or those with high risk of exposure, expanding in later phases the administration to another populations. There can be controversy in vaccinating some specific gynecological groups, like pregnant women, lactating women or patients with gynecological cancer. The purpose of this article is to analyze the information available regarding vaccination in these concrete groups.